Invitrogen Looks To Limit Damages From Patent Suit

Law360, New York (October 3, 2007, 12:00 AM EDT) -- Life sciences company Invitrogen Corp. on Tuesday filed a motion that seeks to limit the potential damages in a lawsuit that accuses it of infringing a patent related to the introduction of DNA into the nucleus of living cells.

In a motion for partial summary judgment, Invitrogen alleged that Genetic Applications LLC should be barred from recovering any damages incurred between July 1999 and August 2004.

The Carlsbad, Calif.-based company pointed out that the patent in question “shall be enforceable only for and during such period...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.